Protagonist Therapeutics PTGX Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Protagonist Therapeutics’s reported figures.
Based on the most recent quarter.
The official record: Protagonist Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Protagonist Therapeutics's current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Protagonist Therapeutics's current ratio?
- Protagonist Therapeutics (PTGX) reported current ratio of 17.8× in Q1 2026.
- How has Protagonist Therapeutics's current ratio changed year-over-year?
- Protagonist Therapeutics's current ratio increased by 2.9% year-over-year, from 17.3× to 17.8×.
- What is the long-term trend for Protagonist Therapeutics's current ratio?
- Over 5 years (2020 to 2025), Protagonist Therapeutics's current ratio has grown at a 10.1% compound annual growth rate (CAGR), from 7.8× to 12.7×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.